AVITA Medical Inc
NASDAQ:RCEL

Watchlist Manager
AVITA Medical Inc Logo
AVITA Medical Inc
NASDAQ:RCEL
Watchlist
Price: 3.42 USD -1.44% Market Closed
Market Cap: 104.3m USD

During the last 3 months AVITA Medical Inc insiders have not bought any shares, and have not sold any shares. The stock price has dropped by 37% over this period (open performance analysis).

The last transaction was made on Aug 28, 2025 by Mcnamara Robert , who bought 45k USD worth of RCEL shares.

Last Transactions:
Mcnamara Robert
$+45k
O'toole David D
$+9k
Mcnamara Robert
$+50k
O'toole David D
$+9.6k
Mcnamara Robert
$+91.3k
O'toole David D
$+9.9k
Mcnamara Robert
$+100.9k
O'toole David D
$+10.3k
Crowe Suzanne
$+6.4k
O'toole David D
$+6k
O'toole David D
$+4.6k
O'toole David D
$+17.4k
Corbett James
$-19.2k
Cook Jeremy Curnock
$-31.2k
Cook Jeremy Curnock
$-30.9k
O'toole David D
$+11.8k
O'toole David D
$+5.3k
O'toole David D
$+10.3k
O'toole David D
$+12.2k
O'toole David D
$+12.5k
O'toole David D
$+13.3k
O'toole David D
$+12.9k
Shiroma Donna
$-66.4k
O'toole David D
$+17.1k
O'toole David D
$+17.9k
O'toole David D
$+16.2k
Perry Michael S
$-1.1m
Perry Michael S
$-94.5k
Crowe Suzanne
$+18.2k
Perry Michael S
$-232k
Perry Michael S
$-398.6k
Perry Michael S
$-246.7k
View All Transactions

During the last 3 months AVITA Medical Inc insiders have not bought any shares, and have not sold any shares. The stock price has dropped by 37% over this period (open performance analysis).

The last transaction was made on Aug 28, 2025 by Mcnamara Robert , who bought 45k USD worth of RCEL shares.

Sold
0-3
months
0 USD
0
3-6
months
0 USD
0
6-9
months
0 USD
0
9-12
months
0 USD
0
Bought
0-3
months
No Insider Transactions
0
0 USD
3-6
months
2
113.7k USD
6-9
months
No Insider Transactions
0
0 USD
9-12
months
2
212.4k USD

AVITA Medical Inc
Insider Trading Chart

AVITA Medical Inc
Insiders Performance

1 Week Later 1 Month Later 3 Months Later 6 Months Later 1 Year Later
Average Return
Median Return
Win Rate

AVITA Medical Inc
Last Insider Transactions

Global
Insiders Monitor

AVITA Medical Inc
Glance View

Market Cap
104.3m USD
Industry
Biotechnology

AVITA Medical, Inc., through its subsidiaries, engages in the development and commercialization of technology platform that enables point-of-care autologous skin restoration for multiple unmet needs. The company is headquartered in Valencia California, California. The company went IPO on 2012-03-18. The firm is engaged in developing and commercializing a technology platform, which enables point-of-care autologous skin restoration for multiple unmet needs. The company provides treatment solutions derived from the regenerative properties of a patient’s own skin. Its RECELL Autologous Cell Harvesting System (RECELL) enables clinicians to prepare Spray-On Skin Cells, an autologous skin cell suspension, which is sprayed onto the patient to regenerate natural healthy skin. The RECELL System is a single use disposable, stand-alone, battery operated, autologous cell harvesting device containing enzymatic and buffer solutions, sterile surgical instruments, and actuators to achieve the disaggregation and delivery of skin cells. The platform technology of the RECELL System allows for the preparation and delivery of Spray-On Skin Cells, an autologous cellular suspension comprised of the patient’s own skin cells.

RCEL Intrinsic Value
28.14 USD
Undervaluation 88%
Intrinsic Value
Price

What is Insider Trading?

Insider trading refers to the buying or selling of a company’s stock by individuals with access to non-public, material information about the company.

While legal insider trading occurs when insiders follow disclosure rules, illegal insider trading involves trading based on confidential information and is prohibited by law.

Why is Insider Trading Important?

It isn't a coincidence that corporate executives seem to always buy at the right times. After all, they have access to every bit of company information you could ever want.

However, the fact that company executives have unique insights doesn't mean that individual investors are always left in the dark. Insider trading data is out there for all who want to use it.

Peter Lynch

Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.

Back to Top